Efficacy of Probiotics Combined with Enteral Nutrition Therapy on Intestinal Flora, Digestive Tract Symptoms and Endogenous Environment in Patients with Gastric Cancer Undergoing Chemotherapy

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2024 Nov 18

PMID 39554672

Authors

Lan Yang

Yuzhu Liang

Riheng Li

Yuan Chen

Xia Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effects of probiotics combined with enteral nutrition therapy on intestinal flora, digestive tract symptoms and endogenous environment in patients with gastric cancer undergoing chemotherapy.

Methods: In this retrospective study, eighty patients with gastric cancer undergoing chemotherapy admitted to Affiliated Hospital of Hebei University from January 2021 to September 2023 were included and divided into two groups by random number table method: the enteral nutrition group and the probiotics combined enteral nutrition group (n=40 each group). The differences in the number of intestinal flora, nutritional indicators, immune function, endotoxin, D-lactic acid levels between the two groups, and the digestive tract symptoms of the two groups before and after treatment were compared and recorded.

Results: The levels of serum total protein (TP), prealbumin (PAB), albumin (ALB) and transferrin (TF) in both groups were higher than those before treatment, and those in the probiotics combined with enteral nutrition group were higher than those in the enteral nutrition group (p< 0.05). The levels of immunoglobulin A (lgA), immunoglobulin M (lgM) and immunoglobulin G (lgG) in the two groups were lower than before treatment, and those in the probiotics combined with the enteral nutrition group were lower than those in the enteral nutrition group (p< 0.05).

Conclusion: Probiotics combined with enteral nutrition results in various benefits in the treatment of patients with gastric cancer undergoing chemotherapy, improving immunity, and reducing gastrointestinal symptoms.

References

Zheng C, Chen T, Lu J, Wei K, Tian H, Liu W . Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy. Food Funct. 2021; 12(14):6294-6308. DOI: 10.1039/d1fo01375k. View

Yang J, Zhou X, Liu X, Ling Z, Ji F . Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment. Front Microbiol. 2021; 12:641322. PMC: 8005548. DOI: 10.3389/fmicb.2021.641322. View

Zhao X, Wang Y, Yang Y, Pan Y, Liu J, Ge S . Association between preoperative nutritional status, inflammation, and intestinal permeability in elderly patients undergoing gastrectomy: a prospective cohort study. J Gastrointest Oncol. 2022; 13(3):997-1006. PMC: 9274063. DOI: 10.21037/jgo-22-367. View

Kasahara K, Kunisaki C, Sato S, Kondo H, Takahashi M, Tamura Y . Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer. Anticancer Res. 2023; 43(6):2841-2850. DOI: 10.21873/anticanres.16453. View

Jiao J, Li W, Shang Y, Li X, Jiao M . Clinical effects of Chemotherapy combined with Immunotherapy in patients with advanced NSCLC and the effect on their nutritional status and immune function. Pak J Med Sci. 2023; 39(2):404-408. PMC: 10025708. DOI: 10.12669/pjms.39.2.6365. View

Li H, Zhang S, Lin L, Rastogi S . Does enteral immune nutrition (EIN) boost the immunity of gastric cancer (GC) patients undergoing surgery? A systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne. 2023; 18(1):31-41. PMC: 10091918. DOI: 10.5114/wiitm.2022.120768. View

Jacobson A, Yang D, Vella M, Chiu I . The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol. 2021; 14(3):555-565. PMC: 8075967. DOI: 10.1038/s41385-020-00368-1. View

Yang D, Meng X, Wang Y, Zhang J, Zhao Y, Zheng Z . Effects of probiotics on gastric cancer-related inflammation: A systematic review and meta-analysis. J Food Biochem. 2022; 46(5):e14034. DOI: 10.1111/jfbc.14034. View

Dai D, Yang Y, Yu J, Dang T, Qin W, Teng L . Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 2021; 12(12):1104. PMC: 8613192. DOI: 10.1038/s41419-021-04396-y. View

10.

Joshi S, Badgwell B . Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021; 71(3):264-279. PMC: 9927927. DOI: 10.3322/caac.21657. View

11.

Ma L, Zhang H . Machine learning algorithm of ultrasound-mediated intestinal function recovery and nursing efficacy analysis of lower gastrointestinal malignant tumor after surgery. Pak J Med Sci. 2021; 37(6):1662-1666. PMC: 8520359. DOI: 10.12669/pjms.37.6-WIT.4866. View

12.

Shen J, Dai S, Li Z, Dai W, Hong J, Huang J . Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis. Front Nutr. 2022; 9:941975. PMC: 9277464. DOI: 10.3389/fnut.2022.941975. View

13.

Wang Z, Han W, Xue F, Zhao Y, Wu P, Chen Y . Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation. Gut. 2022; 71(12):2391-2400. DOI: 10.1136/gutjnl-2021-325948. View

14.

Al-Dorzi H, Arabi Y . Nutrition support for critically ill patients. JPEN J Parenter Enteral Nutr. 2021; 45(S2):47-59. DOI: 10.1002/jpen.2228. View

15.

Li K, Wang D, Zhang X, Yang J, Chen X . Efficacy of early enteral nutrition versus total parenteral nutrition for patients with gastric cancer complicated with diabetes mellitus: A systematic review and meta-analysis. Nutr Diet. 2022; 79(1):129-139. DOI: 10.1111/1747-0080.12721. View

16.

De Lazzaro F, Alessandri F, Tarsitano M, Bilotta F, Pugliese F . Safety and efficacy of continuous or intermittent enteral nutrition in patients in the intensive care unit: Systematic review of clinical evidence. JPEN J Parenter Enteral Nutr. 2022; 46(3):486-498. DOI: 10.1002/jpen.2316. View

17.

Schiessel D, Orrutea A, Tramontt C, Vicente Cavagnari M, Novello D, Macedo D . Clinical and nutritional characteristics on overall survival impact in patients with gastrointestinal cancer. Clin Nutr ESPEN. 2022; 48:336-341. DOI: 10.1016/j.clnesp.2022.01.021. View

18.

Li N, Bai C, Zhao L, Sun Z, Ge Y, Li X . The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer. Front Oncol. 2022; 11:781697. PMC: 8733568. DOI: 10.3389/fonc.2021.781697. View

19.

Carrillo Lozano E, Oses Zarate V, Campos Del Portillo R . Nutritional management of gastric cancer. Endocrinol Diabetes Nutr (Engl Ed). 2021; 68(6):428-438. DOI: 10.1016/j.endien.2020.09.005. View